Lotus Pharmaceuticals, Inc.

$0.00+0.00%(+$0.00)
TickerSpark Score
33/100
Poor
60
Valuation
20
Profitability
20
Growth
36
Health
30
Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LTUS research report →

52-Week Range13% of range
Low $0.00
Current $0.00
High $0.01

Companylotuspharmaceuticalsusa.com

Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China.

CEO
Zhong Yi Liu
IPO
2005
Employees
233
HQ
Nashville, TN, US

Price Chart

-39.75% · this period
$0.01$0.01$0.00May 19Nov 17May 19

Valuation

Market Cap
$98.77K
P/E
88.30
P/S
0.00
P/B
0.00
EV/EBITDA
0.92
Div Yield
0.00%

Profitability

Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
0.00%
ROIC
0.00%

Growth & Income

Revenue
$0 · 0.00%
Net Income
$-29,031 · -126.15%
EPS
$0.00 · 0.00%
Op Income
$-29,031
FCF YoY
0.00%

Performance & Tape

52W High
$0.01
52W Low
$0.00
50D MA
$0.00
200D MA
$0.00
Beta
-1.69
Avg Volume
1.81K

Get TickerSpark's AI analysis on LTUS

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime

Recent Insider Transactions

DateInsiderTypeShares
Aug 21, 07WASSERMAN ADAM Cother50,000
May 31, 07WASSERMAN ADAM Cother44,200
Jan 6, 04NIERENBERG DAVIDother25,000
Nov 22, 02NIERENBERG DAVIDbuy7,500
Oct 18, 01NIERENBERG DAVIDbuy10,000
Aug 25, 03NIERENBERG DAVIDother41,700
Aug 25, 03NIERENBERG DAVIDother41,700
May 1, 03NIERENBERG DAVIDother0

Our LTUS Coverage

We haven't published any research on LTUS yet

For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.

Generate LTUS Report →

Similar Companies